The use of therapeutic peptides to target and to kill cancer cells.
about
Current and potential applications of host-defense peptides and proteins in urologypH Dependent Antimicrobial Peptides and Proteins, Their Mechanisms of Action and Potential as Therapeutic AgentsEvaluation of the use of therapeutic peptides for cancer treatmentThe CT20 peptide causes detachment and death of metastatic breast cancer cells by promoting mitochondrial aggregation and cytoskeletal disruption.Physicochemical properties and in vitro cytotoxicity of iron oxide-based nanoparticles modified with antiangiogenic and antitumor peptide A7R.Antitumor activity of SA12, a novel peptide, on SKBr-3 breast cancer cells via the mitochondrial apoptosis pathwayHigh-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs AntagonistsPhotosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy.A biomimetic approach for enhancing the in vivo half-life of peptides.Rational development of a cytotoxic peptide to trigger cell death.Expression and purification of toxic anti-breast cancer p28-NRC chimeric proteinNovel Engineered Peptides of a Phage Lysin as Effective Antimicrobials against Multidrug-Resistant Acinetobacter baumannii.Biomedical applications of nisin.Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy.Peptide-Membrane Interactions by Spin-Labeling EPRMonofunctional and higher-valent platinum anticancer agents.Lipid raft-mediated miR-3908 inhibition of migration of breast cancer cell line MCF-7 by regulating the interactions between AdipoR1 and Flotillin-1.Exploring the therapeutic potential of jellyfish venom.Beyond peptides and mAbs--current status and future perspectives for biotherapeutics with novel constructs.THPdb: Database of FDA-approved peptide and protein therapeuticsPeptide nanostructures in biomedical technology.DNA nanomaterials for preclinical imaging and drug deliveryPotential role of bioactive peptides in prevention and treatment of chronic diseases: a narrative review.CancerPPD: a database of anticancer peptides and proteins.A BODIPY-embedding miltefosine analog linked to cell-penetrating Tat(48-60) peptide favors intracellular delivery and visualization of the antiparasitic drug.Raman spectroscopy using plasmonic and carbon-based nanoparticles for cancer detection, diagnosis, and treatment guidance. Part 2: Treatment.The role of natural antimicrobial peptides during infection and chronic inflammation.Chaperonin Containing TCP-1 Protein Level in Breast Cancer Cells Predicts Therapeutic Application of a Cytotoxic Peptide.Multisite aggregation of p53 and implications for drug rescue.MLACP: machine-learning-based prediction of anticancer peptides.Aptamer-mediated selective delivery of a cytotoxic cationic NHC-Au(i) complex to cancer cells.Peptides as drug delivery vehicles across biological barriersElucidation of Therapeutic Peptide Binding Partners from Isolated Mitochondria
P2860
Q27027719-9B1BF463-1479-445F-93ED-ED9C35B2D4ABQ28070241-574A59E7-55C6-4393-B74C-476B132673F4Q29048586-E5561B84-CB10-4775-BD62-B2874D927FCBQ30580090-D4F63C4E-7011-4F55-A8BE-D20CA8D5FC0CQ30847079-F93CFEF6-C705-4D62-B83F-DF3DA3C04040Q35161655-C621FE74-8852-421D-BDA8-37089C9CA9C8Q35634594-387B6AA0-308D-4008-B160-E63D37B29F6DQ35851983-AFA206BA-61D6-4950-8577-E281BD5E1483Q36073308-B18CD5AC-1C77-40CA-804E-4484CD35D29BQ36279284-331191E1-C364-4D88-A532-C977949D6F92Q36861349-898CA154-F736-49EA-9D4B-7AEA2BB7FA18Q36887978-A182CF9B-6587-4F6B-93CC-7F22A84C6C23Q36900890-E9F961C7-A141-4F75-B4D6-E5B5F097A721Q37224751-E89ADD8E-CAD1-4751-B928-788087F22075Q37226855-C9E3ABEB-F8C6-4539-A752-C605132F29B6Q37282213-A3B03C92-2132-45EC-8512-4511BE23DA93Q37715551-1622CBD7-A9B7-4863-8FD0-D8E93FD12B1AQ38269168-CF936A9B-FC23-4AAB-B1EE-F47806A24E80Q38364462-45322FCC-6472-4B86-A408-B661D41CA298Q38651596-525627A7-B003-434B-B71C-DEB9C60AC769Q38723306-C0E59544-F432-4C38-BD5C-EEC32BA424D5Q38831073-4B887C56-3326-4DC7-BD0B-41B1B9AF5464Q38940037-03585645-E77F-49E7-82BF-FD465D754F41Q38951733-C15EBC86-9667-4098-BEA5-8B4203BF9E03Q39032576-464C4258-2463-4220-8E11-DDFE6354BED3Q39180555-93FEBACD-9D20-4079-B011-C89328274170Q40063866-F9F76B83-3A31-4EBB-A2CE-BA8E60A9ABFFQ41009989-11B24A1F-2126-4EBE-B0E3-8F8FA5339493Q41677793-8A919778-2C22-4236-AC4D-BD6ADC2A0EB1Q45944202-F463B402-F8DF-443A-B08C-25015A337AB1Q52421731-481A29A3-62FF-44AC-B90F-5E489BBA6028Q56889662-FCE9A8AF-C8C7-4F1E-AF39-3F0AA69637CDQ58571662-B4F87693-D1D8-4991-831F-A5644513A642
P2860
The use of therapeutic peptides to target and to kill cancer cells.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The use of therapeutic peptides to target and to kill cancer cells.
@ast
The use of therapeutic peptides to target and to kill cancer cells.
@en
type
label
The use of therapeutic peptides to target and to kill cancer cells.
@ast
The use of therapeutic peptides to target and to kill cancer cells.
@en
prefLabel
The use of therapeutic peptides to target and to kill cancer cells.
@ast
The use of therapeutic peptides to target and to kill cancer cells.
@en
P2093
P2860
P1476
The use of therapeutic peptides to target and to kill cancer cells.
@en
P2093
A R Khaled
P Vishnubhotla
R J Boohaker
P2860
P304
P356
10.2174/092986712801661004
P577
2012-01-01T00:00:00Z